Andere talen HOOKIPA Pharma Inc.

Aandelen

HOOK

US43906K1007

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 24-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,8 ^USD	-23,08%		-1,89%	-1,23%

23/05	HOOKIPA Pharma Inc. kondigt positieve klinische gegevens aan die zullen worden gepresenteerd op de jaarlijkse bijeenkomst van de American Society for Clinical Oncology in 2024	CI
09/05	HOOKIPA Pharma Inc. rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

HOOKIPA Pharma Inc. Announces Positive Clinical Data to Be Presented At the American Society for Clinical Oncology 2024 Annual Meeting	23/05
HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical Oncology 2024 Annual Meeting	23/05
HOOKIPA Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights	09/05
HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab	25/04
HOOKIPA Pharma Inc. Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab	25/04
HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers	24/04
HOOKIPA Pharma Inc. Announces FDA Clearance of Its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers	24/04
HOOKIPA Pharma Announces Grant of Inducement Award under Nasdaq Listing Rule 5635(4)	17/04
HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)	16/04
HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration	10/04
HOOKIPA Pharma Inc. Announces European Medicines Agency Grant Prime Designation for the Investigational Product HB-200	10/04
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights	25/03
HOOKIPA Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	22/03
HOOKIPA Pharma Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22/03
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights	22/03
North American Morning Briefing : Stocks Struggle After New Records	22/03
North American Morning Briefing : Stock Futures -2-	13/03
HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference	06/03
HOOKIPA Pharma to Cut 30% of Workforce in Restructuring	29/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen HOOKIPA Pharma Inc.

Aandelen

HOOK

US43906K1007

Andere talen

Filters